Skip to main content
. 2024 Jun 3;9:142. doi: 10.1038/s41392-024-01853-w

Table 1.

Patient characteristics

Patient no. Age (y) Sex Histology Tumor sites (primary and metastatic) Eastern Cooperative Oncology Group No. of previous systemic therapies 68Ga-FAPI-46 (SUVmax baseline) Status Follow-up (d)
1 60 Woman Breast Cancer Lung, liver, bone, brain, soft tissue 3 3 12.5 Deceased 26
2 77 Man Prostatic Cancer Prostate, lymph nodes 1 3 19.7 Deceased 38
3 77 Man Gastric Cancer Gastric, lung, lymph nodes 0 4 16.2 Deceased 79
4 19 Woman Breast Cancer Lung, liver, lymph nodes 2 6 9.2 Deceased 60
5 60 Woman Breast Cancer Bone 3 7 24.7 Follow-up 115